Enzon Pharmaceuticals News

KANSAS CITY, Kan. and NEW YORK, May 9, 2012 /PRNewswire/ -- Aratana Therapeutics, an animal health company developing innovative medicines for companion animals, has announced the appointment of Craig Tooman, to its Board of Directors.

Enzon Pharmaceuticals, Inc. and Hisun Announce Strategic Alliance for Enzon's Customized PEGylation Linker Technology and Licensing Agreement for PEG-SN38 in China PISCATAWAY, NJ and ZHEJIANG, CHINA-- - Enzon Pharmaceuticals, Inc.

Biopharmaceutical maker Enzon Pharmaceuticals, said that at the special meeting held yesterday its stockholders have approved the sale of Enzon's specialty pharmaceutical business to Italian owned Sigma-Tau Group.

New Jersey-based biopharmaceutical products maker for life-threatening ailments, Enzon Pharmaceuticals Inc,.today disclosed having entered into a definitive agreement to sell its specialty pharmaceutical business to Italian pharma group Sigma-Tau for $300 million plus an additional amount of up to $27 million based on success milestones.

Enzon Pharmaceuticals Inc plans to spin off its novel biotechnology business from Enzon and list it as a separate company.